[Beijing Direct News Network August 18th] (Kangting)In order to improve the effectiveness of Party building, further actively serve enterprises, and promote the transformation of biomedical achievements and the docking of incubation projects, the Joint Research Institute organized R & D personnel of R & D center, experts of incubation enterprises and cooperative medical institutions to visit Kangting bioengineering Group Co., Ltd. to carry out various exchanges and project docking with the company's leaders and technical personnel. Huang Yalou, Secretary of the Party committee of the United Research Institute; Yin zhanchun, vice president; Professor Sun Tao, member of the Party committee and director of the Key Laboratory of Chengji medicine; Wang bangmao, director of the General Hospital of Tianjin Medical University; Gao Wenqing, director of Tianjin Third Central Hospital; accompanied by Zhang Haiying, deputy director of Xiqing District and Shi Guosheng, chairman of Xiqing Economic Development Corporation; and Liu Xiaobing, chairman of Kangting group President Yang Qi and Secretary Yang Zhen warmly received the visiting delegation of the Research Institute.

The delegation of the research institute first visited the Biomedical Research Institute of Kangting group to learn more about its research and development of new technologies in the fields of stem cells and anti-aging; After that, we visited the infrastructure construction site of Kanghui hospital, skin care products production and R & D center, analysis and testing CNAs platform and other core departments. We showed Kangting group's modern production workshop, automated logistics storage system and strict standard quality control system, reflecting the enterprising style and strong cultural heritage of modern high-tech enterprises. The delegation had an in-depth discussion and exchange with leaders of Xiqing District and Kangting group. Both sides agreed that the joint research institute and Kangting group would find a large number of cooperation entry points in new technology research and development, project transformation, clinical medical treatment and social services, and realize "hospital enterprise" in-depth cooperation, so as to jointly make new and greater contributions to the biomedical industry.

In order to implement the orientation given by the municipal Party committee and the municipal government to the Research Institute, promote the achievement transformation and project cooperation, the two sides jointly held a maker roadshow and project promotion meeting. Six scholars from the United Research Institute, the General Hospital of Tianjin Medical University, the third Central Hospital of Tianjin and science and technology enterprises carried out project reports and cooperation exchanges, covering functional active materials, new drug research and development, medical information technology and other fields. Among them, Zhang Bo, deputy researcher of the platform Department of the Research Institute, introduced the latest achievements in the research of traditional Chinese medicine and network pharmacology, Gao Wenqing, director of the third Central Hospital, introduced the research and development of new bioactive polysaccharide materials, Dr. Liu Huijuan of the Key Laboratory of pharmaceutical properties of the Research Institute introduced innovative drugs and new molecules of innovative skin care products, and young PI zhongweilong of the general hospital introduced Dr. Wang Huan and Dr. Chang zisong, makers of the Research Institute, also demonstrated the new achievements and progress of precision medical technology in the fields of medical information networking and diagnostic reagent development. Experts and responsible comrades in charge of the enterprise conducted in-depth communication and exchange, and fully affirmed the effectiveness of this activity.

The Research Institute will further enhance the level of Party building service business, make new initiatives and do practical work, continuously strengthen the service industry and service enterprises, actively build a platform, provide landing and transformation conditions for enterprises and innovative projects in an all-round way, promote the rapid realization of downstream connection of high-tech, bridge the R & D and transformation, and promote the development of biomedical industry with high quality.